Biosensors International Group, Ltd.
U.S. patent granted covering drug-eluting stent technology
Published in Biotech Law Weekly, October 14th, 2005
Specifically, this U.S. patent, (Patent Number 6939376) covers the use of anti-restenotic, immuno-suppressive drugs including Everolimus, in combination with a biodegradable drug-release polymer coating on an endovascular stent. The patent was filed in April 2002, and is valid in the U.S. for 20 years from the filing date. The company has also filed for the same patent in Australia, Japan and Europe, which it is anticipating to receive.
''Intellectual assets are...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-10-14)
More Articles from Biotech Law Weekly
- Albany Molecular Research, Inc.
Chemistry-based drug discovery firm adds three people to management team - Alnylam Pharmaceuticals, Inc.
Intellectual property licensed for MicroRNA gene involved in hepatitis C - Avitar, Inc.
U.S. patent secured for oral fluid DNA test - Epitan, Ltd.
Ethics approval obtained for PMLE trial in Melbourne - Generex Biotechnology Corp.
Buccal drug delivery company receives Canadian patents - Implant Sciences Corp.
U.S. CMS payment code issued for radioactive treatment source - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
